Launched Passion 1st Fund, a SGD $100 Million Fund, maintaining a target return of 10 per cent per annum since inception and distributed quarterly dividends.

Ranked in the top 10 per cent of financial performers based on benchmarking against global comparator funds for 2020, 2021, 2022 and 2023.
‍

Launched Passion TradeChamp Fund, maintaining an annualised return of 10% over the past 3 years and distributing 5% dividends every 6 months.

Launched Passion Global fund , with an annualised return of more than 10% to date.

Expansion into China, with its approved US$200 million QFLP fund by Chinese Financial regulators.

Portfolio company Syantra: Early breast cancer testing using a sample of blood instead of mammogram

Partnering with Chintai (a CMS licensed company) to launch its Passion Biotech and MedTech Global fund to investors and banking partners as well as Alliance partners.

Working with Haikou team to develop smart City in Jiangdong

Partnering Moovita (Singapore based Autonomous bus company) to expand its footprint into China